F19.25
Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.25 refers to a condition where an individual develops a dependence on certain psychoactive substances, leading to a substance-induced psychotic disorder. This diagnosis highlights the complex interaction between substance use and mental health, emphasizing the importance of recognizing both dependence and its psychiatric effects. People affected by this condition may experience significant disruptions to their mental and physical well-being, requiring comprehensive assessment and management.
Causes & Symptoms
Clinical Causes: Chronic use of psychoactive substances such as opioids, stimulants, hallucinogens, or sedatives Repeated or high-dose consumption that leads to physical and psychological dependence Genetic predisposition to substance dependence and mental health disorders Environmental factors promoting substance use, such as peer pressure or stress Comorbid mental health conditions that increase vulnerability to substance dependence
Key Symptoms: Psychotic episodes, including hallucinations or delusions, influenced by substance use Cravings and compulsive seeking of psychoactive substances Altered perception, thinking, or mood depending on the substance consumed Behavioral changes such as agitation, confusion, or paranoia Physical signs of substance use like dilated pupils, tremors, or rapid heartbeat Periods of mental stability interrupted by psychotic symptoms during or after substance intake
Diagnostic & Treatment
Diagnosis Path: Patient interviews regarding substance use patterns and mental health history Physical examinations and laboratory tests to detect substance levels Psychiatric evaluations to assess the presence of psychotic features Use of standardized diagnostic criteria to confirm dependence and substance-induced psychosis
Treatment Protocols: Detoxification procedures to safely manage withdrawal symptoms Psychosocial interventions, including counseling or therapy, like cognitive-behavioral therapy (CBT) Pharmacological treatments to address psychotic symptoms, such as antipsychotic medications Medication-assisted treatments (MAT) for managing dependence, where appropriate Support groups and rehabilitation programs to promote long-term recovery Monitoring and follow-up care to prevent relapse and manage ongoing mental health issues
Clinical Advice & FAQs
Billing Guidance
Is F19.25 a billable ICD-10 code?
Yes, F19.25 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.25?
Clinical documentation must specify the nature of Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference